IP Library Granted Patent US 10,973,993
Granted Patent B2
US 10,973,993 · App. 16/272,669 · Granted Apr 13, 2021

Anti-run dry membrane

Inventors: Shaun Staley (Murray, UT); Weston O. Whitaker (Riverton, UT); Jon Larsen (Riverton, UT)
Assignee: Becton, Dickinson and Company
A61M5/38A61M5/1411A61M5/36A61M5/44B01D53/62A61M5/385
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,973,993
App. No.
16/272,669
Granted
Apr 13, 2021
Kind
B2
Abstract

An intravenous delivery system may have a liquid source containing a liquid, tubing, and an anti-run-dry membrane positioned such that the liquid, flowing form the liquid source to the tubing, passes through the anti-run-dry membrane. The anti-run-dry membrane may have a plurality of pores through which the liquid flows, and may be formed of a hydrophilic material that resists passage of air through the pores. The intravenous delivery system may further have a bubble point raising component that raises the bubble point of the anti-run-dry membrane. The bubble point raising component may, in some embodiments, be a high surface energy coating or additive.

Claims (22)

1. An intravenous delivery system comprising:

a drip unit, comprising:

an exterior wall;

a cartridge disposed within the exterior wall, wherein the cartridge comprises an outer wall and an inner wall, wherein the outer wall comprises a plurality of slots, wherein the inner wall comprises another plurality of slots; and

an anti-run-dry membrane retained within the cartridge between the outer wall and the inner wall;

tubing coupled to the exterior wall, wherein the anti-run-dry membrane is positioned such that liquid flowing towards the tubing passes through the anti-run-dry membrane, wherein the anti-run-dry membrane comprises a plurality of pores through which the liquid flows, wherein the anti-run-dry membrane is formed of a hydrophilic material configured to resist passage of air through the pores; and

a bubble point raising component configured to raise a bubble point of the anti-run-dry membrane.

2. The intravenous delivery system of claim 1 , wherein the anti-run-dry membrane is formed of a membrane material having a membrane surface energy, wherein the bubble point raising component comprises a coating applied to the anti-run-dry membrane, wherein the coating is formed of a coating material comprising a coating surface energy higher than the membrane surface energy.

3. The intravenous delivery system of claim 1 , wherein the anti-run-dry membrane is formed primarily of a membrane material having a membrane surface energy, wherein the bubble point raising component comprises an additive added to the membrane material prior to formation of the anti-run-dry membrane, wherein the additive is formed of an additive material comprising an additive surface energy higher than the membrane surface energy.

4. The intravenous delivery system of claim 1 , wherein the anti-run-dry membrane is formed of a hydrophilic material, wherein the anti-run-dry membrane comprises a roughened surface finish that increases wettability of the anti-run-dry membrane.

5. The intravenous delivery system of claim 1 , wherein the bubble point raising component comprises a liquid cooling unit that cools the liquid before the liquid contacts the anti-run-dry membrane to raise the bubble point of the anti-run-dry membrane.

6. The intravenous delivery system of claim 1 , wherein, during flow of the liquid through the anti-run-dry membrane toward the tubing, the anti-run-dry membrane comprises a nonplanar shape.

7. The intravenous delivery system of claim 6 , wherein the nonplanar shape comprises a generally tubular shape.

8. The intravenous delivery system of claim 6 , wherein the anti-run-dry membrane comprises a membrane material that has been plastically deformed by application of a manufacturing process configured to stretch the anti-run-dry membrane into the nonplanar shape.

9. The intravenous delivery system of claim 6 , wherein of the effective pore size is less than 3 micrometers.

10. The intravenous delivery system of claim 9 , wherein the anti-run-dry membrane comprises a thickness of less than 90 micrometers.

11. The intravenous delivery system of claim 1 , wherein the exterior wall comprises a shelf, wherein the cartridge rests on the shelf.

12. The intravenous delivery system of claim 1 , wherein the exterior wall comprises a peripheral portion, wherein the peripheral portion is generally tubular or a frustoconical shape.

13. The intravenous delivery system of claim 12 , wherein the drip unit further comprises a drip feature that determines a rate at which the liquid is received by the drip unit, wherein the peripheral portion is proximate the drip feature.

14. The intravenous delivery system of claim 1 , further comprising a liquid source containing a liquid and in fluid communication with the drip unit.

15. The intravenous delivery system of claim 1 , wherein the other plurality of slots extends longitudinally along a length of the inner wall.

16. The intravenous delivery system of claim 1 , wherein the plurality of slots extends longitudinally along a length of the outer wall.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 8, 2019
From: STALEY, SHAUN; WHITAKER, WESTON O.; LARSEN, JON
To: BECTON, DICKINSON AND COMPANY
Reel/Frame 048823/0840 →
Continuity (3)
Division 15078709 · Mar 23, 2016
Provisional Application 62138706 · Mar 26, 2015
Related Publication 20190167914A1 · Jun 6, 2019